TNF Indicates Likelihood of Patient Response to Costly IBD Treatment Before Initiation of Therapy SAN DIEGO, CA / ACCESS ...

An editorial in Brain Medicine calls for urgent action to address the often-overlooked toxicity of commonly prescribed drugs.

Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will discuss ...

About one-third of patients had changes in a specific combination of four genes - BRCA2, CDH1, RHOA and TP53 - and those patients were more likely to die from their cancer or have it return ...

Also, would a combination of these drugs result in greater symptomatic relief and an improvement in peak urinary flow (Q max)? The first question has largely been answered by a 4-year trial with ...

China's major industrial enterprises achieved a significant turnaround in profitability in the first quarter of 2025, with profits of enterprises above the designated size rebounding from a 3.3 ...

Your new baby, is such a marvel. Every time you look at this lovely child, you can't help but believe that there's a bit of both of you in this bubba. So why not think of names that actually contain ...

Subjects in the open-label trial were randomised to receive either a combination therapy featuring Keytruda or standard of care (SOC) radiotherapy alone. Findings from the initial interim analysis ...

1 Department of Medical Genetics, Centre for Molecular Medicine & Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada 2 Department of Clinical Genetics, Centre for Human ...

Click Keyboard Manager, then select Remap a key to re-assign individual keys or Remap a shortcut to assign hotkey combinations to a single key. Click the + button, then set the key and map it to a ...

Pivotal Phase 3 CREST trial results show a 32% reduction in the risk of disease-related events, including high-grade disease recurrence or progression, with sasanlimab in combination with standard of ...